Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHP3: Oxytocin for PPH prevention in preeclampsia
NCT02221830Phase 1Completed
- Sponsor
- University of Colorado Denver
- Start
- Feb 2015
- Primary completion
- Jul 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin in postpartum hemorrhage (PPH), sponsored by University of Colorado Denver. Primary endpoint: Postpartum hematocrit at 24 hours. Started Feb 2015; status: completed.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02221830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02221830.